Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

11 New Telehealth Services Will Be Payable By CMS During Pandemic, Agency Says

Reimbursements will be available via telemedicine for neurostimulator analysis and cardiac rehabilitation, among other services

Executive Summary

The US Medicare agency will allow reimbursements for a bevy of new telemedicine services during the COVID-19 public health emergency, it announced on 14 October.

You may also be interested in...



US CMS Should Delay Adjustment In Pay For E/M Services Until COVID-19 Crisis Passes: Device Firms

Medtech companies commenting on the proposed 2021 Medicare physician fee schedule expressed concerns about lowered payments to surgeons and doctors during the COVID-19 crisis.

CMS To Pay Clinicians For Telehealth Services During COVID-19 Outbreak

In a change likely to expand use of telemedicine, clinicians will be reimbursed for remote conversations and services to Medicare beneficiaries for the duration of the COVID-19 outbreak, CMS administrator Seema Verma said on 17 March.

Seating Of Barrett On Supreme Court Could Be Death Knell For ACA’s Chronic Illness Coverage

During her confirmation hearings, Judge Amy Coney Barrett denied it’s her goal to end all Affordable Care Act coverage, but some senators and legal experts disagree. And if the ACA is struck down, coverage for chronic disease treated with medical devices – including cancer, heart disease and diabetes – could fall by the wayside.

Topics

UsernamePublicRestriction

Register

LL1134211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel